OncoCyte Corp (OCX) — Cash Flow Quality Index

Latest as of March 2023: -3.19x

OncoCyte Corp (OCX) has a Cash Flow Quality Index of -3.19x as of March 2023. Operating cash flow of $-9.67 Million is below net income of $3.03 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore OncoCyte Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-3.19x

Operating CF / Net Income

Operating Cash Flow

$-9.67 Million

USD

Net Income

$3.03 Million

USD

Data as of

Mar 2023

Most recent filing

Annual Cash Flow Quality Index for OncoCyte Corp (None–None)

Year-by-year earnings quality comparison for OncoCyte Corp.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.